Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Mantzoros

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Metabolism: Clinical and Experimental|January 20, 2019
Fibroblast growth factor 21: A role in cardiometabolic disorders and cardiovascular risk prediction?Niki Katsiki, Christos Mantzoros
American Journal of Infectious Diseases|December 22, 2006
Leptin and Adiponectin in the HIV Associated Metabolic Syndrome: Physiologic and Therapeutic ImplicationsSotirios Tsiodras, Christos Mantzoros
Metabolism: Clinical and Experimental|August 11, 2020
Making progress towards a better pathophysiological understanding and more promising therapeutic options for treating non-alcoholic steatohepatitis (NASH)/DASH (dysmetabolism associated steatohepatitis)Niki Katsiki, Christos Mantzoros
Nestle Nutrition Institute Workshop Series|March 19, 2013
Early growth and development of later life metabolic disordersJoo-Pin Foo, Christos Mantzoros
The Journal of Endocrinology|July 25, 2014
20 years of leptin: role of leptin in human reproductive disordersSharon H Chou, Christos Mantzoros
Metabolism: Clinical and Experimental|November 7, 2017
Bone metabolism in anorexia nervosa and hypothalamic amenorrheaSharon H Chou, Christos Mantzoros
Expert Review of Clinical Pharmacology|August 4, 2022
Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetesManfredi Rizzo, Francesco Cosentino, Christos Mantzoros
Metabolism: Clinical and Experimental|March 31, 2020
New American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: Placing them into a practicing physician's perspectiveNiki Katsiki, Ele Ferrannini, Christos Mantzoros
Metabolism: Clinical and Experimental|July 14, 2019
Effects of sodium-glucose co-transporter-2 (SGLT2) inhibitors on non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Ex quo et quo vadimus?Niki Katsiki, Nikolaos Perakakis, Christos Mantzoros
Current Vascular Pharmacology|April 29, 2020
Abnormal Peri-organ-Intra-organ Fat (APIFat) and Rheumatoid Arthritis: An Under-investigated Link for Increased Cardiovascular Risk?Niki Katsiki, Dimitri P Mikhailidis, Christos Mantzoros
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Metabolism: Clinical and Experimental|January 20, 2019
Fibroblast growth factor 21: A role in cardiometabolic disorders and cardiovascular risk prediction?Niki Katsiki, Christos Mantzoros
American Journal of Infectious Diseases|December 22, 2006
Leptin and Adiponectin in the HIV Associated Metabolic Syndrome: Physiologic and Therapeutic ImplicationsSotirios Tsiodras, Christos Mantzoros
Metabolism: Clinical and Experimental|August 11, 2020
Making progress towards a better pathophysiological understanding and more promising therapeutic options for treating non-alcoholic steatohepatitis (NASH)/DASH (dysmetabolism associated steatohepatitis)Niki Katsiki, Christos Mantzoros
Nestle Nutrition Institute Workshop Series|March 19, 2013
Early growth and development of later life metabolic disordersJoo-Pin Foo, Christos Mantzoros
The Journal of Endocrinology|July 25, 2014
20 years of leptin: role of leptin in human reproductive disordersSharon H Chou, Christos Mantzoros
Metabolism: Clinical and Experimental|November 7, 2017
Bone metabolism in anorexia nervosa and hypothalamic amenorrheaSharon H Chou, Christos Mantzoros
Expert Review of Clinical Pharmacology|August 4, 2022
Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetesManfredi Rizzo, Francesco Cosentino, Christos Mantzoros
Metabolism: Clinical and Experimental|March 31, 2020
New American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: Placing them into a practicing physician's perspectiveNiki Katsiki, Ele Ferrannini, Christos Mantzoros
Metabolism: Clinical and Experimental|July 14, 2019
Effects of sodium-glucose co-transporter-2 (SGLT2) inhibitors on non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Ex quo et quo vadimus?Niki Katsiki, Nikolaos Perakakis, Christos Mantzoros
Current Vascular Pharmacology|April 29, 2020
Abnormal Peri-organ-Intra-organ Fat (APIFat) and Rheumatoid Arthritis: An Under-investigated Link for Increased Cardiovascular Risk?Niki Katsiki, Dimitri P Mikhailidis, Christos Mantzoros
Pageof 9